Brief: IQ-AI Ltd Says FDA Grants Orphan Status To Gallium Maltolate For Treating GBM

Imaging Biometrics

28/02/2023 15:54

Feb 28 (Reuters) - IQ-AI Ltd  IQAI.L :
    * IQ-AI LIMITED  - ORPHAN DRUG DESIGNATION STATUS
    * IQ-AI LTD - UNITED STATES FDA GRANTED ORPHAN DRUG
DESIGNATION
STATUS FOR GALLIUM MALTOLATE FOR TREATMENT OF GLIOBLASTOMA
MULTIFORME BRAIN CANCER

Source text for Eikon:  ID:nRSb3886Ra 
Further company coverage:  IQAI.L 

 ((Reuters.Briefs@thomsonreuters.com;))